Insider

Alnylam Pharmaceuticals, Inc.

ALNY Health Care · No analyses yet

1 insider sale recorded.

Mentioned in recent filings: Ukraine Tariffs

What changed

No articles about this company yet. Follow it to hear when the first one appears.

Sector peers

How this company compares with 36 covered companies in Health Care (median revenue change +7.2% YoY), from archived SEC XBRL filings.

CompanyLatest revenueRevenue YoYOperating margin
Alnylam Pharmaceuticals, Inc. ALNY———
Unitedhealth Group Inc UNH$113B-0.4%5.8%
Mckesson Corp MCK$111B+7.6%1.4%
CVS Health Corp CVS$108B+5.4%3.3%
Cigna Group CI$73.7B+5.6%3.3%
Cardinal Health Inc CAH$67.5B+5.5%1.1%
Elevance Health, Inc. ELV$51.4B+1.4%2.5%

Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.

Insider trades

DatePersonTradeSharesAvg. priceValueFiling
October 2, 2026Bryan SupranSale1,758$226.88$398,855SEC

All insider trades →

Large funds (13F)

FundSharesValueChange in sharesQuarter
Fidelity (FMR)15,023,962$4,522,663,249+3.1%Q2 2026
BlackRock10,907,675$3,283,537,489+4.4%Q2 2026
Capital Research Global Investors9,750,699$2,935,115,324+3.0%Q2 2026
State Street3,555,689$1,070,369,060+7.0%Q2 2026
Geode Capital Management2,635,840$791,345,610-0.9%Q2 2026
Norges Bank (Norway's sovereign fund)2,271,813$683,883,867—Q2 2026
Wellington Management2,110,407$635,295,819+9.0%Q2 2026
Two Sigma Investments1,875,937$564,713,315-5.9%Q2 2026
D. E. Shaw & Co.1,104,109$332,369,932+4.3%Q2 2026
Millennium Management316,001$95,125,781-29.4%Q2 2026
Citadel Advisors191,029$57,505,460+715.8%Q2 2026
Bridgewater Associates99,584$29,977,772-6.6%Q2 2026
T. Rowe Price1,149,201$345,945-19.8%Q2 2026

From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.